Effect of nifedipine on the differentiation of human dental pulp cells cultured with mineral trioxide aggregate

J Endod. 2013 Jun;39(6):801-5. doi: 10.1016/j.joen.2012.12.037. Epub 2013 Feb 14.

Abstract

Introduction: Mineral trioxide aggregate (MTA) can induce differentiation of the dental pulp cells into odontoblast-like cells and generate a dentin-like mineral structure. The mechanisms underlying MTA-induced odontoblastic differentiation in human dental pulp cells (HDPCs) are not completely understood. The purpose of this study was to evaluate the effect of nifedipine as calcium channel blocker on MTA-induced odontoblastic differentiation in HDPCs.

Methods: HDPCs extracted from maxillary supernumerary incisors and third molars were directly cultured on MTA with or without nifedipine in the culture medium. Cell growth and expression of odontoblastic differentiation markers were determined by using methyl-thiazol-diphenyl-tetrazolium assay and reverse transcription-polymerase chain reaction analysis, respectively. Phosphorylation of mitogen-activated protein kinase was measured by Western blotting, and calcium deposition was assessed by using alizarin red S staining.

Results: MTA at a concentration of 1 mg/mL significantly up-regulated the expression of dentin sialophosphoprotein and dentin matrix protein-1 and enhanced mineralized nodule formation. However, nifedipine attenuated the MTA-induced odontoblastic differentiation in HDPCs. In addition, MTA-induced mineralization was blocked by inhibition of extracellular signal-regulated kinase (ERK), p38, and Jun N-terminal kinase (JNK) by using U0126, SB203580, and SP600125, respectively. Furthermore, phosphorylation of ERK and JNK in response to MTA was inhibited when the medium was supplemented with nifedipine.

Conclusions: This study showed that calcium ions released from MTA play an important role in odontoblastic differentiation of HDPCs via modulation of ERK and JNK activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aluminum Compounds / pharmacology*
  • Anthracenes / pharmacology
  • Butadienes / pharmacology
  • Calcium / analysis
  • Calcium Channel Blockers / pharmacology*
  • Calcium Compounds / pharmacology*
  • Cell Culture Techniques
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Culture Media
  • Dental Pulp / cytology
  • Dental Pulp / drug effects*
  • Drug Combinations
  • Extracellular Matrix Proteins / analysis
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Humans
  • Imidazoles / pharmacology
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / analysis
  • Nifedipine / pharmacology*
  • Nitriles / pharmacology
  • Odontoblasts / drug effects
  • Oxides / pharmacology*
  • Phosphoproteins / analysis
  • Pyridines / pharmacology
  • Root Canal Filling Materials / pharmacology*
  • Sialoglycoproteins / analysis
  • Silicates / pharmacology*
  • Tooth Calcification / drug effects
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Aluminum Compounds
  • Anthracenes
  • Butadienes
  • Calcium Channel Blockers
  • Calcium Compounds
  • Culture Media
  • DMP1 protein, human
  • Drug Combinations
  • Extracellular Matrix Proteins
  • Imidazoles
  • Nitriles
  • Oxides
  • Phosphoproteins
  • Pyridines
  • Root Canal Filling Materials
  • Sialoglycoproteins
  • Silicates
  • U 0126
  • dentin sialophosphoprotein
  • mineral trioxide aggregate
  • pyrazolanthrone
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Nifedipine
  • SB 203580
  • Calcium